返回 Agenda
LS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?
Session Chair(s)
Kayoko Kikuchi, PHD
Development Office for Translational Research
Fujita Health University, Japan
Speaker(s)
Hidefumi Nakamura, MD, PHD
National Center for Child Health and Development, Japan
Director for Clinical R&D,
Miyako Matsumizu, MPHARM
Pfizer R&D Japan G.K., Japan
Seiko Bun
Ministry of Health, Labour and Welfare (MHLW), Japan
Kana Harada
Toho University Omori Medical Center, Japan
Child Life Specialist